Belgija - angleščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - perindopril erbumine 8 mg - eq. perindopril 6,676 mg - tablet - 8 mg - perindopril tert-butylamine (= perindopril erbumine) 8 mg - perindopril

Belgija - angleščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

impexeco - perindopril tert-butylamine (= perindopril erbumine) - tablet - 4 mg - perindopril tert-butylamine (= perindopril erbumine) 4 mg - perindopril

Belgija - angleščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

impexeco - perindopril tert-butylamine (= perindopril erbumine) - tablet - 8 mg - perindopril tert-butylamine (= perindopril erbumine) 8 mg - perindopril

Belgija - angleščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

servier benelux sa-nv - perindopril erbumine 4 mg - eq. perindopril 3,338 mg - tablet - 4 mg - perindopril tert-butylamine (= perindopril erbumine) 4 mg - perindopril

Belgija - angleščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

servier benelux sa-nv - perindopril erbumine 8 mg - eq. perindopril 6,676 mg - tablet - 8 mg - perindopril tert-butylamine (= perindopril erbumine) 8 mg - perindopril

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - perindopril erbumine, quantity: 8 mg - tablet, uncoated - excipient ingredients: lactose; magnesium stearate - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of nonfatal myocardial infarction or cardiac arrest.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - perindopril erbumine, quantity: 4 mg - tablet, uncoated - excipient ingredients: lactose; magnesium stearate - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of nonfatal myocardial infarction or cardiac arrest.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - perindopril erbumine, quantity: 2 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of nonfatal myocardial infarction or cardiac arrest.

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - perindopril erbumine - oral tablet - 8mg

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - perindopril erbumine - oral tablet - 4mg